Impact Factor 3.831

Frontiers journals are at the top of citation and impact metrics

This article is part of the Research Topic

Pharmacy Technology and Practice

Original Research ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Pharmacol. | doi: 10.3389/fphar.2018.01352

The Connected Community Pharmacy: Benefits for Healthcare & Implications for Health Policy

  • 1Independent Researcher, United Kingdom

The need for interoperability of healthcare IT systems in order to provide safe, efficient and coordinated healthcare is universally recognised, and various health economies, such as the United Kingdom, the United States and Australia, are seeking to develop regional, state-wide or national systems of healthcare interoperability.
In England, the community pharmacy network is a significant health provider, with important implications for provision of healthcare in deprived areas because of its accessibility. Historically, however, community pharmacies have operated on a silo basis, and have not shared information on their activities with, or been able to access information from, other NHS healthcare providers. The development of services such as the Electronic Prescription Service and the Summary Care Record in England have helped to connect community pharmacy with the NHS infrastructure, and more comprehensive systems and datasets are proposed to integrate community pharmacy with the NHS in future.
This paper will review the benefits of the connected community pharmacy, based on developments to date, describe some of the future developments that will support the connected community pharmacy, and discuss some of the implications for pharmacists and health policy makers.

Keywords: interoperability, Connected Community Pharmacy, Electronic prescription service, summary care record, Pharmacy services

Received: 27 Jul 2018; Accepted: 05 Nov 2018.

Edited by:

Syed Shahzad Hasan, University of Huddersfield, United Kingdom

Reviewed by:

Fathi M. Sherif, University of Tripoli, Libya
Rani Khatib, University of Leeds, United Kingdom  

Copyright: © 2018 Goundrey-Smith. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dr. Stephen J. Goundrey-Smith, Independent Researcher, Chedworth, Cheltenham, Glos, United Kingdom, sgspharma@hotmail.com